StockMarketWire.com - Braveheart Investment Group has announced that it has agreed terms to sell its interest in Biopta to ReproCELL, a Japanese listed company.

The total consideration is to be satisfied as to approximately 50% in cash and 50% in ReproCELL shares.




Story provided by StockMarketWire.com